Pathogen-specific T cell polyfunctionality is a correlate of T cell efficacy and immune protection

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Boyd, Anders ^a   Almeida, Jorge R ^b   Darrah, Patricia A ^c   Sauce, Delphine ^b   Seder, Robert A ^c   Appay, Victor ^b   Gorochov, Guy ^b,d   Larsen, Martin ^b,d  

^a INSTITUT PIERRE LOUIS D EPIDÉMIOLOGIE ET DE SANTÉ PUBLIQUE   (France)

^b Assistance publique Hôpitaux de Paris   (France)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL KILLING; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; LEISHMANIASIS; NONHUMAN; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL CLONE; CYTOTOXICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; IMMUNOPHENOTYPING; INFORMATION PROCESSING; INNATE IMMUNITY; LEISHMANIA MAJOR; PARASITOLOGY; PATHOLOGY; SKIN LEISHMANIASIS; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

LEISHMANIA MAJOR;

CYTOKINE;

ALGORITHMS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLONE CELLS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DATASETS AS TOPIC; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; IMMUNOPHENOTYPING; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTE SUBSETS;

EID: 84934948132     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128714     Document Type: Article

References (19)

1. Radaelli A, Bonduelle O, Beggio P, Mahe B, Pozzi E, Elli V, et al. Prime-boost immunization with DNA, recombinant fowlpox virus and VLP(SHIV) elicit both neutralizing antibodies and IFNgamma-producing T cells against the HIV-envelope protein in mice that control env-bearing tumour cells. Vaccine. 2007; 25(11):2128-38. Epub 2007/01/24. S0264-410X(06)01198-4 [pii] doi: 10.1016/j.vaccine.2006.11.009 PMID: 17241705.
2. Appay V, Douek DC, Price DA. CD8+ T cell efficacy in vaccination and disease. Nat Med. 2008; 14(6):623-8. Epub 2008/06/07. nm.f.1774 [pii] doi: 10.1038/nm.f.1774 PMID: 18535580.
3. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006; 107(12):4781-9. Epub 2006/02/10. 2005-12-4818 [pii] doi: 10.1182/blood-2005-12-4818 PMID: 16467198; PubMed Central PMCID: PMC1895811.
4. Rizzuto GA, Merghoub T, Hirschhorn-Cymerman D, Liu C, Lesokhin AM, Sahawneh D, et al. Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response. J Exp Med. 2009; 206(4):849-66. Epub 2009/04/01. jem.20081382 [pii] doi: 10.1084/jem.20081382 PMID: 19332877; PubMed Central PMCID: PMC2715122.
5. Swadling L, Capone S, Antrobus RD, Brown A, Richardson R, Newell EW, et al. A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory. Sci Transl Med. 2014; 6(261):261ra153. Epub 2014/11/08. 6/261/261ra153 [pii] doi: 10.1126/scitranslmed.3009185 PMID: 25378645.
6. Yuan J, Gnjatic S, Li H, Powel S, Gallardo HF, Ritter E, et al. CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit. Proc Natl Acad Sci U S A. 2008; 105(51):20410-5. Epub 2008/12/17. 0810114105 [pii] doi: 10.1073/pnas.0810114105 PMID: 19074257; PubMed Central PMCID: PMC2629307.
7. Szaba FM, Kummer LW, Duso DK, Koroleva EP, Tumanov AV, Cooper AM, et al. TNFalpha and IFNgamma but Not Perforin Are Critical for CD8 T Cell-Mediated Protection against Pulmonary Yersinia pestis Infection. PLoS Pathog. 2014; 10(5):e1004142. Epub 2014/05/24. doi: 10.1371/journal.ppat.1004142PPATHOGENS-D-13-03359 [pii]. PMID: 24854422; PubMed Central PMCID: PMC4031182.
8. Peters NC, Pagan AJ, Lawyer PG, Hand TW, Henrique Roma E, Stamper LW, et al. Chronic parasitic infection maintains high frequencies of short-lived Ly6C+CD4+ effector T cells that are required for protection against re-infection. PLoS Pathog. 2014; 10(12):e1004538. Epub 2014/12/05. doi: 10.1371/journal.ppat.1004538 PPATHOGENS-D-14-01337 [pii]. PMID: 25473946; PubMed Central PMCID: PMC4256462.
9. Almeida JR, Sauce D, Price DA, Papagno L, Shin SY, Moris A, et al. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood. 2009; 113(25):6351-60. Epub 2009/04/25. blood-2009-02-206557 [pii] doi: 10.1182/blood-2009-02-206557 PMID: 19389882; PubMed Central PMCID: PMC2710928.
10. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med. 2007; 13 (7):843-50. Epub 2007/06/15. nm1592 [pii] doi: 10.1038/nm1592 PMID: 17558415.
11. Larsen M, Sauce D, Arnaud L, Fastenackels S, Appay V, Gorochov G. Evaluating cellular polyfunctionality with a novel polyfunctionality index. PLoS One. 2012; 7(7):e42403. Epub 2012/08/04. doi: 10.1371/journal.pone.0042403 PONE-D-11-08927 [pii]. PMID: 22860124; PubMed Central PMCID: PMC3408490.
12. Lissina A, Fastenackels S, Inglesias MC, Ladell K, McLaren JE, Briceno O, et al. The link between CD8 + T-cell antigen-sensitivity and HIV-suppressive capacity depends on HLA restriction, target epitope and viral isolate. AIDS. 2014; 28(4):477-86. Epub 2014/01/05. doi: 10.1097/QAD.0000000000000175 PMID: 24384691.
13. Smolen KK, Cai B, Gelinas L, Fortuno ES 3rd, Larsen M, Speert DP, et al. Single-Cell Analysis of Innate Cytokine Responses to Pattern Recognition Receptor Stimulation in Children across Four Continents. J Immunol. 2014. Epub 2014/08/20. jimmunol.1400895 [pii] doi: 10.4049/jimmunol.1400895 PMID: 25135829.
14. Roederer M, Nozzi JL, Nason MX. SPICE: Exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A. 2011; 79A:167-74. Epub 2011/01/11. doi: 10.1002/cyto.a.21015 PMID: 21218431.
15. Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Numerical Recipes 3rd Edition: The Art of Scientific Computing. 3rd ed 2007 10/09/2007.
16. McKinstry KK, Strutt TM, Kuang Y, Brown DM, Sell S, Dutton RW, et al. Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms. J Clin Invest. 2012; 122(8):2847-56. Epub 2012/07/24. 63689 [pii] doi: 10.1172/JCI63689 PMID: 22820287; PubMed Central PMCID: PMC3408751.
17. Larsen M, Arnaud L, Hie M, Parizot C, Dorgham K, Shoukry M, et al. Multiparameter grouping delineates heterogeneous populations of human IL-17 and/or IL-22 T-cell producers that share antigen specificities with other T-cell subsets. Eur J Immunol. 2011; 41(9):2596-605. Epub 2011/06/21. doi:10.1002/eji.201041131 PMID: 21688259.
18. Newell EW, Sigal N, Bendall SC, Nolan GP, Davis MM. Cytometry by Time-of-Flight Shows Combinatorial Cytokine Expression and Virus-Specific Cell Niches within a Continuum of CD8(+) T Cell Phenotypes. Immunity. 2012. Epub 2012/01/24. S1074-7613(12)00004-0 [pii] doi: 10.1016/j.immuni.2012.01.002 PMID: 22265676.
19. Graw F, Regoes RR. Predicting the impact of CD8+ T cell polyfunctionality on HIV disease progression. J Virol. 2014. Epub 2014/06/27. JVI.00647-14 [pii] doi: 10.1128/JVI.00647-14 PMID: 24965450.